Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

UPDATE: Credit Suisse Reiterates On FMC Technologies On Lowered EPS Estimates

Courtesy of Benzinga.

Related FTI
Benzinga's Top Initiations
Credit Suisse Initiates FMC Technologies At Neutral
Energy Stocks Move Higher as Oil Spikes (Fox Business)

In a report published Thursday, Credit Suisse analyst James Wicklund reiterated a Neutral rating on FMC Technologies (NYSE: FTI), but lowered the price target from $72.00 to $62.00.

In the report, Credit Suisse noted, “Expectations were for FTI to report a solid Q3 and show progress toward mid-teen Subsea Technology margins and to affirm that Subsea inbound orders would exceed $5.0bn for 2014 – mission accomplished.Subsea margins were 15.7% (their highest since 2Q10), 15% was blessed for Q4, and inbound orders of $1.1bn (bringing the YTD total to $3.8bn) solidifies the near-term outlook for shares. A major subsea order should come in before year-end and 2015 orders should be as good as 2014. The large project list for 2015 looks good, especially in Africa, but a Feb. election could push one project out. The $0.07 FX charge was from one unhedged project demonstrating the underlying strength in the quarter. The outlook by management was positive, with the caveat that low oil prices could impact business but no signs of that have been seen.”

FMC Technologies closed on Wednesday at $51.83.

Latest Ratings for FTI

Date Firm Action From To
Oct 2014 Credit Suisse Initiates Coverage on Neutral
Sep 2014 FBR Capital Downgrades Outperform Market Perform
Jul 2014 Credit Suisse Maintains Neutral

View More Analyst Ratings for FTI
View the Latest Analyst Ratings

Posted-In: Credit Suisse James WicklundAnalyst Color Price Target Analyst Ratings





UPDATE: Credit Suisse Reiterates On Southwestern Energy Company Following Marcellus/Utica Deal

Courtesy of Benzinga.

Related SWN
UPDATE: Morgan Stanley Reiterates On Southwestern Energy Company Following Marcellus/Utica Properties Acquisition
Dow's Losing Streak Now Stands At 6 Days, S&P 500 And Nasdaq Slightly Positive
Energy Stocks Move Higher as Oil Spikes (Fox Business)

In a report published Thursday, Credit Suisse analyst Arun Jayaram reiterated an Underperform rating on Southwestern Energy Company (NYSE: SWN), but lowered the price target from $41.00 to $36.00.

In the report, Credit Suisse noted, “Mixed emotions. While we applaud SWN management for making a bold acquisition that plays to the company’s core strength (i.e., efficient development of unconventional U.S. resources by harnessing their technical and midstream prowess), we believe it comes at too high of a purchase price as the transaction looks meaningfully dilutive to our NAV and cash flow forecasts. Given rapidly deteriorating natural gas fundamentals, we believe SWN shares are poised to lag its peers, particularly with an equity overhang looming. Lowering target price to $36 from $41 to reflect dilution from the CHK acquisition.”

Southwestern Energy Company closed on Wednesday at $32.54.

Latest Ratings for SWN

Date Firm Action From To
Oct 2014 Credit Suisse Maintains Underperform
Oct 2014 Maxim Group Upgrades Hold Buy
Oct 2014 Morgan Stanley Reinstates Underweight

View More Analyst Ratings for SWN
View the Latest Analyst Ratings

Posted-In: Arun Jayaram Credit SuisseAnalyst Color Price Target Analyst Ratings





Dunkin Brands Shares Spike Down; Miller Tabak Sees Strong EPS Growth

Courtesy of Benzinga.

Related DNKN
Benzinga's Top #PreMarket Losers
How 5 Fast Food Companies Let You Order Ahead With An App
Apple Leads the Charge as Earnings Season Heats Up (Fox Business)

On Thursday, analysts at Miller Tabak commented on Dunkin Brands Group Inc (NASDAQ: DNKN) following the company's earnings report. Miller Tabak currently has a Buy rating and $55 price target on shares of Dunkin Brands.

For Q3 2014, Dunkin Brands reported EPS of $0.49 on revenues of $192.6 million.

Stephen Anderson finds that Dunkin was able to post better-than-expected EPS due to a mix of more aggressive buybacks and tighter controls on costs.

"We think a mix of above-peer same-restaurant sales growth, a solid new unit pipeline, a pullback in dairy prices that we think will boost overseas margins, and share buybacks will support EPS growth above long term guidance in the 2015 – 2016 period."

Shares of Dunkin Brands recently traded at $44.25, down 5.4 percent.

Latest Ratings for DNKN

Date Firm Action From To
Oct 2014 Jefferies Downgrades Buy Hold
Sep 2014 Barclays Maintains Overweight
Aug 2014 Barclays Upgrades Equal-weight Overweight

View More Analyst Ratings for DNKN
View the Latest Analyst Ratings

Posted-In: Miller Tabak Stephen AndersonAnalyst Color Earnings News Price Target Analyst Ratings





Wunderlich Comments On The Cheesecake Factory Following Q3 Earnings

Courtesy of Benzinga.

Related CAKE
The Cheesecake Factory Reports Q3 Hurt By Dairy Costs
The Cheesecake Factory Opens In Sarasota, FL

Following The Cheesecake Factory Incorporated's (NASDAQ: CAKE) third-quarter earnings miss, Wunderlich analyst Robert Derrington issued a note describing his take on the stock.

Derrington began by noting the company posted EPS of $0.48, well below the consensus estimate of $0.57 and the guided range of $0.55-$0.58. According to Derrington, the miss was driven by higher dairy and medical claim costs.

As a result of the the miss, the company's management reduced it fiscal 2014 EPS guidance from $2.19-$2.25 to $2.07-$2.11 and set a fourth quarter EPS range of $0.58-$0.62.

Derrington trimmed his fiscal 2014 EPS estimate from $2.20 to $2.09, and his revenue estimate for the year has gone from $1.975 billion to $1.982 billion on same-store sales growth of 1.7 percent.

Derrington commented, "While Cheesecake Factory continues to generate relatively solid revenue growth, we believe its shares appear fairly valued given its volatile operating trends relative to its valuation."

Derrington reiterated a Hold rating and $46 price target for the stock.

Latest Ratings for CAKE

Date Firm Action From To
Aug 2014 Bank of America Downgrades Buy Underperform
Jul 2014 JP Morgan Maintains Neutral
Jul 2014 Barclays Maintains Equal-weight

View More Analyst Ratings for CAKE
View the Latest Analyst Ratings

Posted-In: Robert DerringtonAnalyst Color Earnings News Guidance Price Target Reiteration Analyst Ratings





JetBlue Announces Its Own Wine Expert, Jon Bonne

Courtesy of Benzinga.

Related JBLU
Earnings Scheduled For October 23, 2014
3 Transportation Stocks to Buy Now
Making Money With Charles Payne: 10/02/14 (Fox Business)

In anticipation of the launch of its new Mint service to San Francisco, JetBlue Airways (NASDAQ: JBLU) today announces its very own wine expert, Jon Bonné. The esteemed wine expert is also the Wine Editor at The San Francisco Chronicle and author of the award-winning book The New California Wine.

In this unique role, Jon is responsible for selecting the wines that will be served onboard JetBlue, specifically the selections for the airline’s premium offering, Mint. As Mint is offered on transcontinental routes from New York’s JFK Airport to Los Angeles International Airport (LAX) and San Francisco International Airport (SFO) (starting October 26, 2014), JetBlue opted to select the very best wines that California has to offer.

“We are continuously working to enhance the Mint experience. The wine menu will undoubtedly be a focal point for those traveling in Mint and we want to offer our customers something that is truly different from anything they can get elsewhere in the sky. As an independent airline, when it came to our wine selection, we decided to work with smaller winemakers with the same entrepreneurial spirit and desire to innovate to ensure that our customers get to discover unique options they wouldn’t find on other airlines,” said Jamie Perry, director of product development, JetBlue Airways. “To bring our unique wine menu to fruition, we partnered with Jon Bonné, who brings his one-of-a-kind wine expertise to JetBlue and will provide our customers with an exceptional wine tasting experience onboard.”

The selection, which will be available onboard shortly, includes a rare treat for those that may like to imbibe in the sky: the Juvenile Zinfandel from Turley Wine Cellars, California’s foremost Zinfandel producer. The range of wines includes selections from other top-quality California producers: Birichino Malvasia Bianca from Monterey County, the Lioco Sonoma County Chardonnay, Copain’s Tous Ensemble Pinot Noir from Mendocino’s Anderson Valley, and Roederer Estate Brut, made by the California outpost of Champagne Louis Roederer.

“It’s incredibly exciting to debut the new…
continue reading





Bank of America Downgrades Ocwen Financial To Neutral

Courtesy of Benzinga.

Related OCN
Ocwen Financial Shares Get Crushed, Bank Of America Downgrades
Markets In Rally Mode: S&P 500 And Nasdaq Surge As Dow Lags

Analysts at Bank of America downgraded Ocwen Financial (NYSE: OCN) from Buy to Neutral.

The price target for Ocwen Financial has been lowered from $35 to $23.

Ocwen Financial shares have dropped 24.28% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period.

Ocwen Financial’s shares dropped 6.70% to $20.04 in pre-market trading.

Latest Ratings for OCN

Date Firm Action From To
Oct 2014 Bank of America Downgrades Buy Neutral
Sep 2014 Barclays Reinstates Equal-weight
Aug 2014 Oppenheimer Downgrades Outperform Market Perform

View More Analyst Ratings for OCN
View the Latest Analyst Ratings

Posted-In: Bank of AmericaDowngrades Analyst Ratings





Oppenheimer Initiates 3D Systems At Outperform

Courtesy of Benzinga.

Related DDD
3D Systems Issues Profit Warning, Shares Tumble
Five 3D Printed Body Parts
Will.i.am Debuts First 3D Printer for 3D Systems (Fox Business)

Analysts at Oppenheimer initiated coverage on shares of 3D Systems (NYSE: DDD) with a Outperform rating.

The target price for 3D Systems is set to $57.

3D Systems shares have dropped 24.28% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period.

3D Systems’ shares tumbled 10.74% to $38.72 in pre-market trading.

Latest Ratings for DDD

Date Firm Action From To
Oct 2014 Oppenheimer Initiates Coverage on Outperform
Sep 2014 Pacific Crest Downgrades Outperform Sector Perform
Sep 2014 Morgan Stanley Initiates Coverage on Equal-weight

View More Analyst Ratings for DDD
View the Latest Analyst Ratings

Posted-In: OppenheimerInitiation Analyst Ratings





UPDATE: Brean Capital Initiates Coverage On GrubHub

Courtesy of Benzinga.

Related GRUB
UPDATE: JMP Securities Initiates Coverage On GrubHub Inc
Benzinga's Top Initiations
Making Money With Charles Payne: 09/25/14 (Fox Business)

Brean Capital initiated coverage on GrubHub Inc (NYSE: GRUB) with a Hold rating.

Analyst Tom Forte noted that "catalysts for the stock include an acceleration in active diner growth or take rate in 3Q14. In our view, its $36.86 share price adequately reflects our favorable opinion of GrubHub and its business model. We would be comfortable recommending their purchase if there was a pullback."

Forte commented that "the company is leading the way as consumers increasingly use their connected devices, including their smartphones, to order online from restaurants instead of calling in their orders and relying on physical menus. Today, only 5 percent of take- out orders are placed online."

"Investor sentiment is already favorable, which is reflected in the high multiples (shares currently trade at an 87.8x forward P/E ratio and 31.9x forward EV/EBITDA). However; we are not forecasting an acceleration, with pro forma active diner growth of 45.0 percent vs. 50.7 percent last quarter and a pro forma take rate of 12.0 percent vs. 14.2 percent last quarter," according to the report.

GrubHub Inc recently traded at $36.81, down 0.38 percent.

Latest Ratings for GRUB

Date Firm Action From To
Oct 2014 Brean Capital Initiates Coverage on Hold
Oct 2014 CRT Capital Initiates Coverage on Buy
Oct 2014 JMP Securities Initiates Coverage on Market Outperform

View More Analyst Ratings for GRUB
View the Latest Analyst Ratings

Posted-In: Brean Capital Tom ForteAnalyst Color Initiation Analyst Ratings





Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan

Courtesy of Benzinga.

Related INNL
Benzinga's Top Initiations
Stifel Nicolas Initiates Innocoll At Buy

Innocoll AG (Nasdaq: INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, today posted to shareholders a proposal to elect Joseph Wiley, M.D., a principal at Sofinnova Ventures, to its Supervisory Board. The Company also announced that Anthony H. Wild, Ph.D., has resigned from Innocoll’s Supervisory Board. If Dr. Wiley’s election is approved, Innocoll will have completed the new composition of its new Supervisory Board. In addition, the Supervisory Board is seeking shareholder support for a stock option plan that will enable it to strengthen and retain the team that will take Innocoll into the commercial stage of its development.

If elected, Dr. Wiley will join other recently appointed Supervisory Board members; Jonathan Symonds, Chairman of the Supervisory Board and former chief financial officer of both Novartis and AstraZeneca, David Brennan, former chief executive officer of AstraZeneca, and Shumeet Banerji, Ph.D., former chief executive officer of Booz & Company. Existing members of the Supervisory Board who will continue to serve in that capacity are A. James Culverwell and Rolf Schmidt.

“We have assembled a highly experienced Supervisory Board comprised of individuals whose corporate and industry expertise is commensurate with the ambitions the Company has for its collagen based products,” said Jonathan Symonds, Chairman of the Supervisory Board. “I look forward to working with these experienced executives and the management team as Innocoll moves to transition into a fully integrated specialty pharmaceutical company.”

Dr. Wiley has over 20 years of experience in the pharmaceutical, medical and venture capital industries. He was previously a medical director at Astellas Pharma. Prior to joining Astellas, he held investment roles at Spirit Capital, Inventages Venture Capital and Aberdeen Asset Managers (UK). Dr. Wiley trained in general medicine at Trinity College Dublin, specializing in neurology. He is also a Member of the Royal College of Physicians in Ireland.

Innocoll also will be seeking shareholder approval to reserve up to 10% of its shares outstanding as contingent capital underlying its proposed stock option plan. This plan will be…
continue reading





Phillips 66 Partners Announces Acquisition of Strategic Logistics Assets

Courtesy of Benzinga.

Phillips 66 Partners LP (NYSE: PSXP) (the “Partnership”) has reached an agreement to acquire from Phillips 66 (NYSE: PSX) two newly constructed crude oil rail-unloading facilities, located in Linden, New Jersey, and Ferndale, Washington, for $330 million as well as certain assets associated with the Cross-Channel Connector Pipeline for an additional $10 million. The acquisition, which is anticipated to close in early December 2014, is expected to be immediately accretive to unitholders.

“The acquisition of these high-quality logistics assets will enhance both the composition and geographic diversity of the Partnership’s portfolio,” said Greg Garland, Phillips 66 Partners chairman and CEO. “These strategically positioned assets will allow us to deliver on our plans for achieving top-quartile distribution growth.”

The assets to be acquired include:

The Bayway Rail-unloading Facility located within the Phillips 66 Bayway Refinery. This facility started commercial operations in August 2014, and is capable of unloading 120 railcars simultaneously, with a crude-unloading capacity of 75,000 barrels per day.
The Ferndale Rail-unloading Facility located adjacent to the Phillips 66 Ferndale Refinery. This facility is scheduled to begin commercial operations in November 2014 and will be capable of unloading 54 railcars simultaneously with a crude-unloading capacity of 30,000 barrels per day.
The Cross-Channel Connector Pipeline assets consisting of an active 2.5-mile, 20-inch diameter refined products pipeline, as well as an idled, 2.6-mile, 20-inch diameter refined products pipeline that runs under the Houston Ship Channel. The active segment currently transports refined products between the Partnership’s Pasadena Terminal and Kinder Morgan’s Pasadena Terminal.
Upon closing of the acquisition, the Partnership plans to utilize the Cross-Channel Connector Pipeline assets to develop and undertake a new organic project to provide shippers access from the Partnership’s Pasadena Terminal to third-party systems located north of the Houston Ship Channel. The project is expected to have additional capital costs of $12.4 million and is underwritten by long-term transportation service agreements with multiple shippers. The pipeline system will have an initial capacity of up to 180,000 barrels per day and is anticipated to commence commercial operations in the second quarter of 2015.

In connection with the closing, Phillips 66 and the Partnership will enter into 10-year terminal services agreements for 100 percent…
continue reading





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!

 
 

Zero Hedge

Ebola Fears Take Shine Off Panic-Buying Surge In Stocks

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Buyback-manipulated earnings produced the low-volume opening face-ripper everyone wanted and stocks took off, recovering yesterday's late losses and not looking back.Trannies were the big winners, led by a resurgence in Airlines (as Ebola in US is fixed) and, despite drastically lower than average volume, stocks kept lifting after EU close on a bed of AUDJPY and USDJPY... until 1450ET (when NYC Ebola headlines hit). Airlines were hit hard, S&P futures dumped back to VWAP, VIX was whacked back above 17, and the exuberant day transformed into merely a great day for stocks. Weakness in Treasuries and the HY bond ETF (despite notable compression in HY spreads) had the sm...



more from Tyler

Phil's Favorites

French Private Sector Output Falls at Sharpest Rate in Eight Months; Tale of Two Europes

Courtesy of Mish.

France

Looking for growth in Europe? You won't find it in France, but for now you can still find it in Germany (for now).

The Markit Flash France PMI shows French private sector output falls at sharpest rate in eight months.
Key Points

  • Flash France Composite Output Index falls to 48.0 (48.4 in September), 8-month low
  • Flash France Services Activity Index falls to 48.1 (48.4 in September ), 8-month low
  • Flash France Manufacturing Output Index falls to 47.6 (48.4 in September ), 2-month low
  • Flash France Manufacturing PMI falls to 47.3 (48.8 in September), 2-month low

Summary

The latest flash PMI data signalled a deepenin...



more from Ilene

Chart School

A Long-Term Look at Inflation

Courtesy of Doug Short.

The Consumer Price Index for Urban Consumers (CPI-U) released this yesterday puts the September year-over-year inflation rate at 1.66%, off the May 19-month high of 2.13%. It is well below the 3.87% average since the end of the Second World War and 29 percent below its 10-year moving average.

For a comparison of headline inflation with core inflation, which is based on the CPI excluding food and energy, see this monthly feature.

For better understanding of how CPI is measured and how it impacts your household, see my Inside Look at CPI components.

For an even closer look at how the components are behaving, see this X-Ray View of the data for the past six months.

The Bureau of Labor Statistics (BLS) has compiled CPI...



more from Chart School

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Insider Scoop

UPDATE: Credit Suisse Reiterates On FMC Technologies On Lowered EPS Estimates

Courtesy of Benzinga.

Related FTI Benzinga's Top Initiations Credit Suisse Initiates FMC Technologies At Neutral Energy Stocks Move Higher as Oil Spikes (Fox Business)

In a report published Thursday, Credit Suisse analyst James Wicklund reiterated a Neutral rating on FMC Technologies (NYSE: FTI), but lowered the price target from $72.00 to $6...



http://www.insidercow.com/ more from Insider

Option Review

LUV Options Active Ahead Of Earnings

There is lots of action in Southwest Airlines Co. November expiry call options today ahead of the air carrier’s third-quarter earnings report prior to the opening bell on Thursday. Among the large block trades initiated throughout the trading session, there appears to be at least one options market participant establishing a call spread in far out of the money options. It looks like the trader purchased a 4,000-lot Nov 37/39 call spread at a net premium of $0.40 apiece. The trade makes money if shares in Southwest rally 9.0% over the current price of $34.32 to exceed the effective breakeven point at $37.40, with maximum potential profits of $1.60 per contract available in the event that shares jump more than 13% to $39.00 by expiration. In September, the stock tou...



more from Caitlin

Sabrient

Sector Detector: Sharp selloff in stocks sets up long-awaiting buying opportunity

Courtesy of Sabrient Systems and Gradient Analytics

Last week brought even more stock market weakness and volatility as the selloff became self-perpetuating, with nobody mid-day on Wednesday wanting to be the last guy left holding equities. Hedge funds and other weak holders exacerbated the situation. But the extreme volatility and panic selling finally led some bulls (along with many corporate insiders) to summon a little backbone and buy into weakness, and the market finished the week on a high note, with continued momentum likely into the first part of this week.

Despite concerns about global economic growth and a persistent lack of inflation, especially given all the global quantitative easing, fundamentals for U.S. stocks still look good, and I believe this overdue correction ultimately will shape up to be a great buying opportunity -- i.e., th...



more from Sabrient

Digital Currencies

Goodbye War On Drugs, Hello Libertarian Utopia. Dominic Frisby's Bitcoin: The Future of Money?

Courtesy of John Rubino.

Now that bitcoin has subsided from speculative bubble to functioning currency (see the price chart below), it’s safe for non-speculators to explore the whole “cryptocurrency” thing. So…is bitcoin or one of its growing list of competitors a useful addition to the average person’s array of bank accounts and credit cards — or is it a replacement for most of those things? And how does one make this transition?

With his usual excellent timing, London-based financial writer/actor/stand-up comic Dominic Frisby has just released Bitcoin: The Future of Money? in which he explains all this in terms most readers will have no tr...



more from Bitcoin

OpTrader

Swing trading portfolio - week of October 20th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Market Shadows

Falling Energy Prices: Sober Look takes a Sober Look

Falling Energy Prices: Sober Look takes a Sober Look

What do falling energy prices mean for the US consumer? Sober Look writes a brief yet thorough overview of the consequences of the correction in the price of crude oil. There are good aspects, particularly for the consumer, bad aspects, and out-right ugly possibilities. For more on this subject, read James Hamilton's How will Saudi Arabia respond to lower oil prices?  In previous eras, Saudi Arabia would tighten the supply to help increase prices, but in this "game of chicken," the rules m...



more from Paul

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's this week's Stock World Weekly. Just sign in with your PSW user name and password. (Or take a free trial.)

#457319216 / gettyimages.com

 

...

more from SWW

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>